
SCIEX
Advertisement
Articles by SCIEX
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease
2
Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targeting T Cell Engager to Roche
3
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
4
Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program
5


